Table 1.
Baseline characteristics of the different groups.
| Characteristic | Stepwise group |
TPO-RA group (n = 33) |
|
|---|---|---|---|
| Monotherapy group |
Combination therapy group |
||
| n = 110 | n = 12 | n = 21 | |
| Gender (male:female) | 53:57 | 8:4 | 11:10 |
| Race (n) | |||
| Asian | 110 | 12 | 21 |
| Baseline age (y), median (IQR) | 6.65 (4.71-10.24) | 6.89 (4.22-9.49) | 8.44 (6.48-10.75) |
| Baseline PLT, (109/L), median (IQR) | 24.00 (12.75-40.25) | 19.00 (12.25-65.00) | 17.00 (6.50-44.00) |
| Baseline bleeding score, grade (n) | |||
| Grade 0 | 28 | 3 | 3 |
| Grade 1 | 47 | 4 | 6 |
| Grade 2 | 24 | 4 | 5 |
| Grade ＞2 | 11 | 1 | 7 |
| Time since ITP diagnosis (mo), median (IQR) | 14.00 (8.75-24.00) | 14.00 (6.50-33.75) | 24.00 (8.50-69.00) |
| Phases of the disease (PITP:CITP) | 43:67 | 5:7 | 10:11 |
CIPT, chronic immune thrombocytopenia; ITP, immune thrombocytopenia; PITP, persistent immune thrombocytopenia; PLT, platelet count; TPO-RA, thrombopoietin receptor agonist.